Courtney Breen
Stock Analyst at Bernstein
(4.57)
# 978
Out of 4,703 analysts
306
Total ratings
89.1%
Success rate
21%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Courtney Breen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly and Company | Maintained: Buy | $1,385 | $1,244.40 | +11.30% | 62 | Sep 1, 2026 | |
| PFE Pfizer | Maintained: Hold | $30 → $29 | $27.79 | +4.35% | 39 | Aug 21, 2026 | |
| BMY Bristol-Myers Squibb Company | Maintained: Hold | n/a | $65.47 | - | 32 | Aug 21, 2026 | |
| MRK Merck & Co. | Maintained: Hold | $100 → $105 | $148.99 | -29.53% | 40 | Aug 19, 2026 | |
| MRNA Moderna | Maintained: Hold | $45 | $133.32 | -66.25% | 42 | Aug 19, 2026 | |
| AMGN Amgen | Maintained: Hold | $335 → $345 | $433.73 | -20.46% | 31 | Aug 5, 2026 | |
| GILD Gilead Sciences | Maintained: Buy | $160 | $143.44 | +11.54% | 30 | Jul 22, 2026 | |
| ABBV AbbVie | Maintained: Hold | $225 | $261.83 | -14.07% | 29 | Jul 22, 2026 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Sell | kr 175.00 | kr 298.84 | -41.44% | 1 | May 12, 2026 |
Eli Lilly and Company
Sep 1, 2026
Maintained: Buy
Price Target: $1,385
Current: $1,244.40
Upside: +11.30%
Pfizer
Aug 21, 2026
Maintained: Hold
Price Target: $30 → $29
Current: $27.79
Upside: +4.35%
Bristol-Myers Squibb Company
Aug 21, 2026
Maintained: Hold
Price Target: n/a
Current: $65.47
Upside: -
Merck & Co.
Aug 19, 2026
Maintained: Hold
Price Target: $100 → $105
Current: $148.99
Upside: -29.53%
Moderna
Aug 19, 2026
Maintained: Hold
Price Target: $45
Current: $133.32
Upside: -66.25%
Amgen
Aug 5, 2026
Maintained: Hold
Price Target: $335 → $345
Current: $433.73
Upside: -20.46%
Gilead Sciences
Jul 22, 2026
Maintained: Buy
Price Target: $160
Current: $143.44
Upside: +11.54%
AbbVie
Jul 22, 2026
Maintained: Hold
Price Target: $225
Current: $261.83
Upside: -14.07%
Novo Nordisk A/S
May 12, 2026
Maintained: Sell
Price Target: kr 175.00
Current: kr 298.84
Upside: -41.44%